Is PBE up or down today?
PBE is up 1.55% today, last at 100.74. This stock moved +1.55% versus the prior close.
PBE · PBE
PBE (PBE) is trading at 100.74, up 1.55% on the session. PBE carries a 14-day RSI of 62, and trades above its 50-day average. Over the past month it is up 3.55%.
Leading the coverage: “Price-Driven Insight from (PBE) for Rule-Based Strategy - Stock Traders Daily” (Google News Company, 7d ago). PBE is +2.59% since story.
PBE trades on a trailing P/E of 22.1 and is running 3.02% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
PBE is up 1.55% today, last at 100.74. This stock moved +1.55% versus the prior close.
Leading the coverage: “Price-Driven Insight from (PBE) for Rule-Based Strategy - Stock Traders Daily” (Google News Company, 7d ago). PBE is +2.59% since story. Dominant story: IBBQ vs. PBE: Which Biotech ETF Is the Better Buy? - The Motley Fool (1 source, neutral) RSI is 62 — leaning bullish Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: May 2026 – Oct 2026 (125 days) · Drag or scroll left for earlier dates
Which Biotech ETF Is the Better Buy: VanEck’s BBH or Invesco’s Factor-Driven PBE? - The Motley Fool
PBE Dec 2026 60.000 put (PBE261218P00060000) interactive stock chart – Yahoo Finance - Yahoo Finance Singapore
Price-Driven Insight from (PBE) for Rule-Based Strategy - Stock Traders Daily
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - Yahoo Finance UK
(PBE) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily